Driven by advances in AI and our ability to generate high-resolution data, the life sciences industry is on the cusp of a second golden age. In this webinar, Sam Scarpino, director of AI + Life Sciences and Adam Bly, CEO of System, will discuss exciting advances at the intersection of AI and Life Sciences, including:
Reducing time-to-market and increasing confidence for therapeutics, biologicals, and diagnostics.
The wet-lab-in-the-loop approach to AI, building platforms for drug discovery, global health security, and a multiomic understanding of the systems biology of disease.
Talent acquisition, upskilling employees, sponsored research, product evaluation, strategy, and more.
Flip through the slides from the presentation here: